Carrasquillo, Robert
Chu, Kevin
Ramasamy, Ranjith
Article History
First Online: 9 June 2018
Compliance with Ethical Standards
:
: Robert Carrasquillo and Kevin Chu each declare no potential conflicts of interest.Ranjith Ramasamy is the lead investigator on clinical trials for use of Natesto in treatment of hypogonadism with Aytu BioScience (ExternalRef removed Identifier NCT03203681).
: This article does not contain any studies with human or animal subjects performed by any of the authors.